Liraglutide in 2025: Diabetes, Weight Loss, and New Updates
Key Highlights What is Liraglutide? Liraglutide is a GLP-1 receptor agonist, a class of medications revolutionizing type 2 diabetes treatment…
Key Highlights What is Liraglutide? Liraglutide is a GLP-1 receptor agonist, a class of medications revolutionizing type 2 diabetes treatment…
In the fight against obesity, sleep is the overlooked game-changer. While diet and exercise steal the spotlight, groundbreaking research reveals…
In the realm of aesthetic medicine, CoolSculpting has revolutionized body contouring as a non-invasive alternative to liposuction. Since its FDA approval in 2010,…
Leading the charge is retatrutide, a next-generation obesity drug developed by Eli Lilly that’s generating unprecedented excitement. Dubbed the “triple agonist,”…
For decades, smoking was branded as the ultimate health villain. Today, researchers warn that “sitting is the new smoking”—a silent killer…
The $1.5 Trillion Weight Loss Economy of 2030: A Breakdown of the Market Reshaping Health By 2030, the global weight…
1. PM Modi’s Anti-Obesity Campaign 2. India’s Obesity Challenge 3. Health Risks of Obesity 4. Why the Definition of Obesity…